Aidi Pharmaceutical announced that the company's technical director, core technical personnel Li Wenquan, Hu Xionglin for personal reasons, respectively, recently applied to resign from the company's technical director, core technical personnel, and has gone through the resignation procedures, Li Wenquan, Hu Xionglin will no longer hold any position in the company after leaving; after Li Wenquan and Hu Xionglin left, the work they are responsible for is responsible for Yuan Yu, executive deputy director of the company's research and development center, and the departure of the above personnel will not affect the company's production and operation and project research and development. It will not affect the core technology and research and development work of the company.
The chairman of the company is Fu Heliang. Mr. Fu Heliang: Born in March 1961, Chinese nationality, doctoral degree, senior engineer, founded Guangdong Tianpu Biochemical Pharmaceutical Co., Ltd. in 1993, served as the director of Guangdong South China New Drug Creation Center from 2012 to 2014, joined Aidi Pharmaceutical as chairman in 2014, served as the general manager of Aidi Pharmaceutical since 2016, and has been the chairman, general manager and CEO of Aidi Pharmaceutical since February 2019.
This article is compiled by the Securities Star Data Center based on publicly available data and does not constitute investment opinions or suggestions, if you have any questions, please contact us.
![Knowing the video lost: demotion, team dissolution, and departure of the number one position[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)